Gangwon, South Korea

Young Jin Kim

This inventor holds 1 USPTO granted patent. Top assignee: Immunemed Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Jin Kim. Retrieved from https://idiyas.com/inventor/young-jin-kim-h5cv97yg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young Jin Kim - Innovator in Antibody Development

Introduction

Young Jin Kim is a notable inventor based in Gangwon-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions for treating viral and inflammatory diseases.

Latest Patents

Young Jin Kim holds a patent for an antibody specifically binding to an isolated peptide derived from vimentin. This invention relates to an antibody that binds to the peptide of SEQ ID NO: 1. The patent encompasses a polynucleotide encoding the antibody, a vector containing the polynucleotide, and a method for producing the antibody using a cell introduced with the vector. Additionally, it includes an antiviral composition and a composition for preventing or treating inflammatory diseases.

Career Highlights

Young Jin Kim is currently associated with Immunemed Inc., where he continues to advance his research and development efforts. His innovative work has the potential to impact the treatment of various infectious viral diseases and inflammatory conditions.

Collaborations

He collaborates with talented coworkers, including Yoon Won Kim and Hyo Jeong Hong, who contribute to the success of their projects at Immunemed Inc.

Conclusion

Young Jin Kim's contributions to antibody development highlight his role as a key innovator in biotechnology. His patent and ongoing research efforts are paving the way for new treatments in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…